Acelyrin, Inc. announced that as previously reported in its Form 8-K filed with the Securities and Exchange Commission (?SEC?) on August 2, 2023, Gil Labrucherie was appointed as the Company?s interim Chief Financial Officer, and in such capacity, began serving as the Company?s principal financial officer and principal accounting officer, effective as of such date. On August 17, 2023, the company appointed Mr. Labrucherie as its full time Chief Financial Officer. In such capacity, he continues to serve as the Company?s principal financial officer and principal accounting officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.2 USD | -0.24% | -8.89% | -43.70% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.70% | 416M | |
+14.84% | 121B | |
+18.31% | 112B | |
+2.94% | 22.72B | |
-18.26% | 20.82B | |
-18.47% | 16.66B | |
-42.36% | 16.36B | |
-14.23% | 16.19B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- SLRN Stock
- News Acelyrin, Inc.
- Acelyrin, Inc. Appoints Gil Labrucherie as Full Time Chief Financial Officer